API
GMED icon

Advisor Partners II’s Globus Medical GMED Stock Holding History

Advisor Partners II’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$441K Buy
+8,882
New +$497K 0.02% 773

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NI
Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Advisor Partners II's GMED Position: Q3 2023 in Review

Advisor Partners II opened a new position in Globus Medical (GMED) in Q3 2023: 8,882 shares worth $441K. The stake represents 0.02% of the portfolio and ranks #773 among its holdings.

431 funds tracked by Wall St. Rank hold GMED as of Q3 2023.

  • Advisor Partners II held 8,882 shares of Globus Medical worth $441K as of Q3 2023.
  • Globus Medical was a new Advisor Partners II position in Q3 2023.
  • Globus Medical made up 0.02% of Advisor Partners II's portfolio in Q3 2023, its #773 holding.
  • 431 funds tracked by Wall St. Rank held Globus Medical as of Q3 2023.

Based on Advisor Partners II's 13F filing for Q3 2023, filed 26 Oct 2023.